What this deck covers
This deck focuses on Drug Names And Therapeutic Classes, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Study Drug Names And Therapeutic Classes in NAPLEX with focused flashcards that help you recognize the idea, recall the key rule, and apply it in practice-style prompts.
0% Complete
What therapeutic class does metoprolol belong to?
Tap card or press Space to flip
Beta-1 selective beta blocker. Selectively antagonizes beta-1 adrenergic receptors in the heart, reducing heart rate and contractility for cardiovascular conditions.
How well did you know it?
Card 1 / 25
Space to flip · ← / → to move · once flipped, → Got it · ← Still learning
This deck focuses on Drug Names And Therapeutic Classes, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.
Answer: Beta-1 selective beta blocker. Selectively antagonizes beta-1 adrenergic receptors in the heart, reducing heart rate and contractility for cardiovascular conditions.
Answer: Selective serotonin reuptake inhibitor (SSRI). Inhibits serotonin reuptake in synaptic clefts, increasing availability for mood regulation in depression and anxiety disorders.
Answer: Loop diuretic. Potently inhibits Na+/K+/2Cl- cotransporter in the loop of Henle, leading to significant diuresis for edema and heart failure.
Answer: Direct thrombin inhibitor (DOAC). Directly inhibits thrombin (factor IIa), blocking fibrinogen conversion to fibrin for anticoagulation in atrial fibrillation.
Answer: Vitamin K antagonist anticoagulant. Inhibits vitamin K-dependent clotting factors (II, VII, IX, X) synthesis in the liver, requiring INR monitoring for anticoagulation.
Answer: Thiazide diuretic. Inhibits sodium reabsorption in the distal convoluted tubule, promoting diuresis and used primarily for hypertension and edema.
Answer: Biguanide antihyperglycemic. Decreases hepatic glucose production and improves insulin sensitivity in type 2 diabetes without causing hypoglycemia.
Answer: Proton pump inhibitor (PPI). Irreversibly inhibits H+/K+ ATPase in parietal cells, suppressing gastric acid secretion for ulcer treatment and GERD.
Answer: P2Y12 inhibitor antiplatelet. Irreversibly inhibits P2Y12 ADP receptors on platelets, preventing aggregation and used for thrombotic event prevention.
Answer: Aldosterone antagonist (potassium-sparing diuretic). Antagonizes mineralocorticoid receptors, promoting sodium excretion while sparing potassium in heart failure and hypertension.
Answer: GLP-1 receptor agonist. Mimics incretin hormone effects, enhancing insulin secretion, suppressing glucagon, and promoting weight loss in diabetes.
Answer: Histamine-2 receptor antagonist (H2RA). Competitively blocks histamine at H2 receptors on parietal cells, reducing basal and stimulated gastric acid secretion.
Answer: Inhaled corticosteroid (ICS). Suppresses airway inflammation by inhibiting pro-inflammatory cytokines and immune cell migration in asthma management.
Answer: Thyroid hormone (T4) replacement. Synthetic form of thyroxine that restores euthyroid state by converting to T3 and regulating metabolism in hypothyroidism.
Answer: HMG-CoA reductase inhibitor (statin). Inhibits the rate-limiting enzyme in cholesterol synthesis, reducing LDL levels and cardiovascular risk.
Answer: Direct factor Xa inhibitor (DOAC). Directly inhibits factor Xa, preventing thrombin generation and clot formation without needing routine monitoring.
Answer: Angiotensin-converting enzyme (ACE) inhibitor. Inhibits the enzyme that converts angiotensin I to II, reducing vasoconstriction and aldosterone release for hypertension management.
Answer: Nitrate antianginal (vasodilator). Releases nitric oxide, causing smooth muscle relaxation and vasodilation to relieve angina by reducing cardiac preload.
Answer: Irreversible COX-1 inhibitor antiplatelet (salicylate NSAID). Acetylates and irreversibly inhibits platelet COX-1, reducing thromboxane A2 and preventing aggregation at low doses.
Answer: Dihydropyridine calcium channel blocker. Blocks L-type calcium channels primarily in vascular smooth muscle, causing vasodilation and blood pressure reduction.
Answer: Angiotensin II receptor blocker (ARB). Selectively blocks angiotensin II at AT1 receptors, preventing vasoconstriction and aldosterone secretion without affecting bradykinin.
Answer: Long-acting basal insulin. Provides steady insulin release mimicking endogenous basal secretion, used for glycemic control in diabetes with low hypoglycemia risk.
Answer: Cholesterol absorption inhibitor. Selectively inhibits cholesterol absorption at the small intestine brush border, lowering LDL without affecting triglycerides much.
Answer: Short-acting beta-2 agonist (SABA). Activates beta-2 adrenergic receptors in bronchial smooth muscle, causing rapid bronchodilation for acute asthma relief.
Answer: SGLT2 inhibitor. Inhibits sodium-glucose cotransporter 2 in kidneys, promoting glucosuria and improving glycemic control with cardiovascular benefits.